Related Experiment Video
Updated: Nov 9, 2025
05:17
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
1.8K
Synthesis and Anticancer Activity of Structure Simplified Naturally-Inspired Dimeric Chromenone Derivatives
Rameez Ali1, Yong Guan1, Alexandria N Leveille1
1Department of Chemistry and Biochemistry, Worcester Polytechnic Institute, 60 Prescott St., Worcester, MA 01602.
European Journal of Organic Chemistry
|April 8, 2021
Summary
Simple dimeric chromenones show anticancer activity against lymphoma and leukemia cells. These easily synthesized compounds are promising lead structures for cancer drug discovery.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Cancer Research
Background:
- Naturally occurring dimeric chromenones and tetrahydroxanthones possess complex structures.
- There is a need for simplified, synthetically accessible compounds with potential anticancer properties.
Purpose of the Study:
- To synthesize and evaluate structurally simplified dimeric chromenone derivatives.
- To identify novel lead compounds for lymphoma and leukemia treatment.
Main Methods:
- Focused library synthesis of dimeric chromenone derivatives.
- Cytotoxicity assays using L5178Y (lymphoma) and HL60 (leukemia) cell lines.
Main Results:
- Several dimeric chromenone derivatives demonstrated low micromolar cytotoxicity.
- The most active compounds were structurally simplified and lacked stereogenic centers.
Conclusions:
- Structurally simplified dimeric chromenones are effective against lymphoma and leukemia cells.
- These compounds represent promising scaffolds for further development in cancer drug discovery.
More Related Videos
Related Concept Videos
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.5K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.5K
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.6K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.6K
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.6K
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
747
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
747
01:28Structure-Activity Relationships and Drug Design
1.4K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.4K